Sugi Predict

Sugi Predict / Compounds / SCHEMBL6294472

SCHEMBL6294472

SCHEMBL6294472

CCCCCCCCCCCCCCCCCCON=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.46
▸ CA1 P00915 8/20 0.43
▸ CA2 P00918 8/20 0.43
▸ CA9 Q16790 7/20 0.43
▸ LPAR3 Q9UBY5 3/20 0.43
▸ CA12 O43570 3/20 0.43
▸ CA7 P43166 3/20 0.43
▸ CA14 Q9ULX7 3/20 0.43
▸ LPAR1 Q92633 2/20 0.43
▸ LPAR2 Q9HBW0 2/20 0.43
▸ CA3 P07451 2/20 0.43
▸ CA4 P22748 2/20 0.43
▸ CA6 P23280 2/20 0.43
▸ CA5A P35218 2/20 0.43
▸ CA5B Q9Y2D0 2/20 0.43
▸ NAAA Q02083 1/20 0.43
▸ DGKA P23743 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.42
▸ TSHR P16473 2/20 0.42
▸ THRB P10828 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27938918 1.00 KMT2A (0.46) KMT2ACA1CA2CA9LPAR3
SCHEMBL11303507 1.00 KMT2A (0.46) KMT2ACA1CA2CA9LPAR3
SCHEMBL15418858 1.00 KMT2A (0.46) KMT2ACA1CA2CA9LPAR3
SCHEMBL8442646 1.00 KMT2A (0.46) KMT2ACA1CA2CA9LPAR3
SCHEMBL294422 1.00 KMT2A (0.46) KMT2ACA1CA2CA9LPAR3
SCHEMBL9220001 1.00 KMT2A (0.46) KMT2ACA1CA2CA9LPAR3
SCHEMBL10331011 1.00 KMT2A (0.46) KMT2ACA1CA2CA9LPAR3
SCHEMBL552425 1.00 KMT2A (0.46) KMT2ACA1CA2CA9LPAR3
SCHEMBL10951377 1.00 KMT2A (0.46) KMT2ACA1CA2CA9LPAR3
SCHEMBL9224792 1.00 KMT2A (0.46) KMT2ACA1CA2CA9LPAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103304549-B Jaspine B, 3-epi Jaspine B triazole class derivative, its preparation method and application thereof ZHENGZHOU UNIVERSITY (CN) 2015-09-02 — — CN claimed
CN-103304549-A Jaspine B, 3-epi Jaspine B triazole derivative as well as preparation method and application thereof UNIV ZHENGZHOU 2013-09-18 — — CN claimed
US-3987090-A HYDROXY ESTERS OF ACRYLIC AND METHACRYLIC ACIDS ROHM GMBH (DT) 1976-10-19 — — US claimed
CN-103304549-B Jaspine B, 3-epi Jaspine B triazole class derivative, its preparation method and application thereof ZHENGZHOU UNIVERSITY (CN) 2015-09-02 — — CN disclosed
CN-103304549-A Jaspine B, 3-epi Jaspine B triazole derivative as well as preparation method and application thereof UNIV ZHENGZHOU 2013-09-18 — — CN disclosed
CN-101428786-A Functional carbon material synthesized with one-step reaction and method for producing the same UNIV ZHEJIANG (CN) 2009-05-13 — — CN disclosed
US-20050222253-A1 Anti-cancer nitro- and thia-fatty acids FERRANTE ANTONIO 2005-10-06 — — US disclosed
US-20050176815-A1 Anti-inflammatory nitro-and thia-fatty acids FERRANTE ANTONIO (AU) 2005-08-11 — — US disclosed
US-20050176817-A1 Anti-inflammatory nitro- and thia- fatty acids FERRANTE ANTONIO (AU) 2005-08-11 — — US disclosed
US-20050176816-A1 Anti-inflammatory nitro- and thia-fatty acids FERRANTE ANTONIO (AU) 2005-08-11 — — US disclosed
US-6924309-B2 Anti-inflammatory nitro and thia-fatty acids CHILDREN, YOUTH AND WOMEN'S HEALTH SERVICE INCORPORATED (AU) 2005-08-02 — — US disclosed
EP-1218333-A4 ANTI-INFLAMMATORY NITRO- AND THIA- FATTY ACIDS WOMENS & CHILDRENS HOSPITAL (AU) 2003-07-09 — — EP disclosed
EP-1218000-A4 ANTI-CANCER NITRO- AND THIA-FATTY ACIDS WOMENS & CHILDRENS HOSPITAL (AU) 2003-07-09 — — EP disclosed
US-20030092762-A1 Anti-inflammatory nitro and thia-fatty acids PEPLIN BIOLIPIDS PTY LTD (AU) 2003-05-15 — — US disclosed
US-20030078299-A1 Anti-cancer nitro- and thia-fatty acids CHILDREN, YOUTH AND WOMEN'S HEALTH SERVICE INCORPORATED (AU) 2003-04-24 — — US disclosed
EP-1218000-A1 ANTI-CANCER NITRO- AND THIA-FATTY ACIDS WOMEN'S AND CHILDREN'S HOSPITAL (AU) 2002-07-03 — — EP disclosed
EP-1218333-A1 ANTI-INFLAMMATORY NITRO- AND THIA- FATTY ACIDS WOMEN'S AND CHILDREN'S HOSPITAL (AU) 2002-07-03 — — EP disclosed
WO-2001021575-A1 ANTI-INFLAMMATORY NITRO- AND THIA- FATTY ACIDS WOMEN'S AND CHILDREN'S HOSPITAL ADELAIDE (AU) 2001-03-29 — — WO disclosed
WO-2001021172-A1 ANTI-CANCER NITRO- AND THIA-FATTY ACIDS WOMEN'S AND CHILDREN'S HOSPITAL ADELAIDE (AU) 2001-03-29 — — WO disclosed
US-3987090-A HYDROXY ESTERS OF ACRYLIC AND METHACRYLIC ACIDS ROHM GMBH (DT) 1976-10-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078299-A1 Anti-cancer nitro- and thia-fatty acids ALOX5, ALOX15, ALOX12 KMT2A 1086/4885CA1 1975/4885CA2 2001/4885
US-20050176815-A1 Anti-inflammatory nitro-and thia-fatty acids PTGES, PTGES2, ALOX5 KMT2A 2043/4885CA1 3519/4885CA2 2026/4885
US-20050222253-A1 Anti-cancer nitro- and thia-fatty acids ALOX5, ALOX15, ALOX12 KMT2A 1344/4885CA1 2330/4885CA2 2386/4885
US-20050176817-A1 Anti-inflammatory nitro- and thia- fatty acids PTGES, PTGES2, ALOX5 KMT2A 2043/4885CA1 3519/4885CA2 2026/4885
US-20030092762-A1 Anti-inflammatory nitro and thia-fatty acids PTGES2, PTGES, PTGS2 KMT2A 1740/4885CA1 3708/4885CA2 1594/4885
US-20050176816-A1 Anti-inflammatory nitro- and thia-fatty acids PTGES, PTGES2, ALOX5 KMT2A 2043/4885CA1 3519/4885CA2 2026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.